PLoS ONE · 2013 · 60 citations · 27 references
MedicineMolecular BiologyOncologyMetastasisMolecular OncologyTumor ProgressionCancer Cell SignalingCancer ProgressionCell-cycle DysregulationJunctional SignalingLung CancerMalignant NeoplasmsCancer Cell Proliferation InhibitionCancer-associated Cyclin-dependent KinasesCyclin D RegulationCyclin RegulationG1/s TransitionLymph Node Metastasis PrognosisTnm Staging SystemTumor Cell Proliferation
The objective of the current study was to determine the clinical significance of junctional adhesion molecule A (JAM-A) in patients with non-small cell lung cancer (NSCLC) and the biological function of JAM-A in NSCLC cell lines. We showed that JAM-A is predominantly expressed in cell membranes and high expression of JAM-A occurred in 37% of lung tumor specimens compared to corresponding normal tissues. High expression of JAM-A was significantly correlated with TNM stage (P = 0.021), lymph node metastasis (P = 0.007), and decreased overall survival (P = 0.02), In addition, we observed that silencing JAM-A by small interfering RNA inhibited tumor cell proliferation and induced cell cycle arrest at the G1/S boundary. Western blotting analysis revealed that knockdown of JAM-A decreased the protein levels of cyclin D1, CDK4, 6, and P-Rb. Thus, JAM-A plays an important role in NSCLC progression.
27
Inés Martín-Padura, Susan Lostaglio, Markus Schneemann et al. · The Journal of Cell Biology · 1998 · 1.4K citations · Full text
Junction Adhesion Molecule Is a Receptor for Reovirus
Erik S. Barton, J. Craig Forrest, Jodi L. Connolly et al. · Cell · 2001 · 638 citations · Full text
Human junction adhesion molecule regulates tight junction resealing in epithelia
Yuan Liu, Asma Nusrat, Frederick J. Schnell et al. · Journal of Cell Science · 2000 · 518 citations